PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31132733-0	2019	L-Fucose ameliorates DSS-induced acute colitis via inhibiting macrophage M1 polarization and inhibiting NLRP3 inflammasome and NF-kB activation.	Fucose	0-8	NLR family pyrin domain containing 3	Homo sapiens	104-109	
31132733-5	2019	In addition, L-fucose can inhibit macrophage M1 polarization, inactivate the NLRP3 inflammasome and reduce the release of TNFalpha, IL1beta, IL6 pro-inflammatory cytokines.	Fucose	13-21	NLR family pyrin domain containing 3	Homo sapiens	77-82	
31132733-6	2019	In vitro studies showed that L-fucose ameliorated cell damage resulting from the administration of LPS with ATP in BMDMs, inhibited NLRP3 inflammasome activation and reduced the release of corresponding pro-inflammatory cytokines.	Fucose	29-37	NLR family pyrin domain containing 3	Homo sapiens	132-137	
31132733-8	2019	Overall, our results show that L-fucose can attenuate colitis by inhibiting macrophage M1 polarization, inhibiting NLRP3 inflammasome and NF-kB activation, and down-regulation of pro-inflammatory cytokines.	Fucose	31-39	NLR family pyrin domain containing 3	Homo sapiens	115-120